Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA May Expand Network Of Experts After Successful CDRH Pilot

This article was originally published in The Pink Sheet Daily

Executive Summary

The Network of Experts, which connects FDA scientists with outside professional societies, has been made a permanent program within the device center.

You may also be interested in...



CDRH’s Shuren Offers Update On “Network Of Experts” Program

The American College of Cardiology, the Society of Thoracic Surgeons and the American Institute for Medical and Biological Engineering have each agreed to lend the knowledge of their members to the device center’s pilot program for tapping outside expertise.

CDRH Has New Plan For Tapping Outside Science Experts

FDA’s device center is in talks with several professional societies and hopes to have its first agreement in place within the month for a pilot program that would allow CDRH to tap outside expertise when pressing scientific questions arise.

CDRH Focusing On New PMA Pathway, Clinical Trials Program In 2014/2015 Priorities

CDRH Director Jeffrey Shuren discussed the device center’s two-year strategic priorities with “The Gray Sheet.” The center plans to rebalance pre-market and post-market data collection, when appropriate, and improve the processes for starting up clinical trials in the U.S.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS074754

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel